Metaverse stocks emerged with a bang a couple of years ago. In fact, Mark Zuckerberg even changed the name of his social media company to Meta Platforms (NASDAQ:META), cementing the idea that the metaverse would be the destination of the future. And yet, there’s little sign of much follow-through on the concept today. So far,
admin
Airline stocks normally don’t move around too much, but they have been quite volatile since the Covid-19 pandemic. Lockdowns decimated the industry, but travel has been recovering. The removal of lockdown restrictions created a “revenge travel” phenomenon that has been going strong for two years. Changes in consumer sentiment can create buying opportunities for investors.
The cannabis market is in disarray. In Canada, where the recreational drug was legalized nationwide in 2018, the market has all but collapsed. High government taxes have pushed cannabis users to a thriving black market while too many companies have oversupplied the legal industry. The result for cannabis companies has been poor sales and plunging
Healthcare is a sector that has underperformed the broader stock market this year. The S&P 500 Health Care Sector Index is down over 2.50% year-to-date versus a 17% gain in the benchmark S&P 500 index. The decline has been broad-based as investors focus their capital allocations on high-flying technology stocks at the expense of pharmaceutical
Bill Nygren, the long-time portfolio manager of the Oakmark Fund (MUTF:OAKMX), recently appeared on Morningstar’s The Long View podcast to discuss the markets. Having managed the $8 billion large-cap fund since 2000, the veteran investor’s hot stock picks are always in demand by investors. In Nygren’s episode, he discusses financial stocks, pointing out that although the
Investors need to be aware of the volatility of their stocks. Owning too many high-volatility positions can create a scenario in which your portfolio loses more than the S&P 500 index during bear markets. The higher the beta, the more volatile the stock is expected to be relative to the S&P 500 index. Low-beta stocks
Many investors are currently seeking safe harbor, given the economic uncertainty and volatility in the market. While explosive growth stocks can generate life-changing gains during bull markets, they often face existential risk during downturns or crises. That’s why even growth-focused investors should allocate a portion of their portfolio to dependable blue-chip stocks. Blue-chip stocks represent
U.S. equities markets have had a decent albeit volatile year thus far, as inflation, interest rates, and geopolitical tensions have, at one time or another, weighed on investor sentiment. Let’s have a look at the numbers. Towards the end of July, the S&P 500 index had reached peak annual performance, at one point returning 19.5%.
A member of the Mississippi National Guard receives a dose of the Moderna COVID-19 vaccine in his arm, in Flowood, Mississippi. Rogelio V. Solis | AP Check out the companies making headlines before the bell. Moderna — Moderna shares rose more than 3% in early trading after the Centers for Disease Control and Prevention recommended updated Covid vaccine
The pharmaceutical industry is one of the most dynamic and innovative sectors in the world. It is constantly developing new drugs and treatments to address various health challenges and improve the quality of life of millions of people. However, not every pharma company is successful in producing positive clinical trial results. If you just took
With the market rallying hard lately, it’s easy to think every stock is participating in the gains. But look a little closer, and you’ll see the rally has been very narrow. Most of these gains have been concentrated heavily in the FAANGs and AI darlings like Tesla (NASDAQ:TSLA) and Nvidia (NASDAQ:NVDA) . Many other high-growth
In this shaky market, many investors seek shelter in stable, mature companies trading at modest valuations. But for those with higher risk appetites, compelling opportunities exist among early-stage disruptors poised for hypergrowth returns. Though more speculative, these emerging innovators can deliver exponential returns if their visions play out. Of course, chasing hypergrowth stocks is risky.
When it comes to communications stocks, knowing which ones to avoid is at least as important as knowing which ones to buy. I would definitely avoid any of the streaming stocks in general, and I’d stay far away from the companies that own both cable channels and streaming channels. That’s because the competition is intense
It makes sense to invest in autonomous driving stocks moving forward. Whether in September or any other month, the research is clear: The market is primed for growth boasting an annual growth rate approaching 23% between this year and 2028. The next five years are bound to produce spectacular gains for investors overall. That’s the
In the dynamic world of stock trading, there’s no denying the importance of knowing which stocks billionaires are selling. Following these financial titans in their investment decisions can be invaluable in navigating the stock market’s volatility. Their access to top-tier research and wealth of experience often shape market trends, unlocking doors to potential investment avenues
Microsoft (NASDAQ:MSFT) shares may be up by more than 40% year-to-date, but as I argued recently, it’s best to dial back expectations for how MSFT stock will perform between now and year’s end. I’m not saying that, after a strong run between January and July, shares in the tech giant are on the verge of
Blue-Chip bargains are a sure way to add value to your portfolio. During high market volatility and uncertainty, identifying sound investment opportunities for long-term growth is akin to finding a pearl at the bottom of a waterfall. However, the bottom contains not one but seven such pearls in the form of Blue-Chip bargains poised for
QuantumScape (NYSE:QS) is a speculative growth stock, but this categorization isn’t what makes QS stock a questionable investment opportunity. You know the saying: nothing ventured, nothing gained. If the odds are in your favor, taking calculated risks in early-stage stocks with a high degree of uncertainty can be a profitable strategy. The issue with this
Previously, we gave EVgo (NASDAQ:EVGO) stock a “D” grade along with a warning for prospective shareholders. Now, even as we uncover more information and developments, we still can’t enthusiastically recommend investing in EVgo. Maybe you’re intrigued with EVgo because you envision vigorous growth in the electric vehicle (EV) charging market. Your optimism is understandable, but EVgo
Lucid Group (NASDAQ:LCID) stock is one I’ve had mixed opinions of in the past. On the one hand, this is a company with some clear speculative upside, particularly as a vehicle for investors to bet on the overall electric vehicle space. However, it’s also clear that Lucid Group is one that has been plagued by